Cargando…
Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis
Although most patients with acute pericarditis will recover, a minority will have recurrent, debilitating episodes. In these patients, refractory symptoms result in high morbidity, and typically require a prolonged duration of anti-inflammatory treatment. Initially, the efficacy of colchicine in bot...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152656/ https://www.ncbi.nlm.nih.gov/pubmed/35639340 http://dx.doi.org/10.1007/s40259-022-00537-7 |